{"rows":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5679,"title":"Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.","authors":"Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I","journal":"Journal of neuroscience methods","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jneumeth.2026.110848","pubmed_id":"42401399","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Biomarkers,Aging,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-09 01:20:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42401399","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42401399","source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","doi":"10.1016/j.jneumeth.2026.110848","pmid":"42401399","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":302,"title":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","authors":"Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš","journal":"Pharmacology Biochemistry and Behavior","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.pbb.2026.174231","pubmed_id":"42379524","openalex_id":"https://openalex.org/W7166640155","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","substance_tags":"psilocin","topic_tags":"Neurogenesis,Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379524","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.pbb.2026.174231","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379524","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","doi":"10.1016/j.pbb.2026.174231","pmid":"42379524","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":120,"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","authors":"Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.","journal":"American Journal of Preventive Medicine","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.amepre.2026.108381","pubmed_id":"42092643","openalex_id":"https://openalex.org/W7160017394","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42092643","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.amepre.2026.108381","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42092643","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","doi":"10.1016/j.amepre.2026.108381","pmid":"42092643","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5783,"title":"Single-crystal structure determination of psilocybin after dehydration","authors":"Emmett Sonya K., Cameron Lee, Hestermann Mark, Holland Darren, Kessler Simon, McFarlane Luke, Chooi Yit-Heng, Moggach Stephen A.","journal":"Acta Crystallographica Section C Structural Chemistry","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1107/s2053229626007692","pubmed_id":"42566287","openalex_id":"https://openalex.org/W7201840591","source_url":"https://doi.org/10.1107/s2053229626007692","substance_tags":"psilocybin","topic_tags":"General","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-08 01:20:18","last_checked":"2026-08-13 01:20:21","bibtex":null,"source_record_id":"PMID:42566287","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1107/s2053229626007692","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42566287","source_url":"https://doi.org/10.1107/s2053229626007692","doi":"10.1107/s2053229626007692","pmid":"42566287","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4197,"title":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.","authors":"Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251381806","pubmed_id":"42539773","openalex_id":"https://openalex.org/W7117566828","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539773","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539773","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","doi":"10.1177/28314425251381806","pmid":"42539773","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4190,"title":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251387655","pubmed_id":"42539824","openalex_id":"https://openalex.org/W7117646156","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539824","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":301,"title":"Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress","authors":"Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki","journal":"Neuropsychopharmacology Reports","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/npr2.70152","pubmed_id":"42379141","openalex_id":"https://openalex.org/W7166665532","source_url":"https://doi.org/10.1002/npr2.70152","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379141","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/npr2.70152","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379141","source_url":"https://doi.org/10.1002/npr2.70152","doi":"10.1002/npr2.70152","pmid":"42379141","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":51,"title":"Balancing safety and access in Oregon’s psilocybin services","authors":"Cheung Katherine, Propes Caleigh, Yaden David B.","journal":"International Journal of Drug Policy","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105384","pubmed_id":"42288041","openalex_id":"https://openalex.org/W7164654902","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288041","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288041","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","doi":"10.1016/j.drugpo.2026.105384","pmid":"42288041","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":50,"title":"Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases","authors":"Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew","journal":"Metabolic Engineering","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.ymben.2026.102490","pubmed_id":"42288133","openalex_id":"https://openalex.org/W7164759173","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Genomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288133","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.ymben.2026.102490","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288133","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","doi":"10.1016/j.ymben.2026.102490","pmid":"42288133","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":46,"title":"Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.","authors":"Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC","journal":"Journal of clinical psychology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/jclp.70167","pubmed_id":"42296474","openalex_id":"https://openalex.org/W7164838909","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42296474","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42296474","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","doi":"10.1002/jclp.70167","pmid":"42296474","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5860,"title":"Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task","authors":"Anderson, D.; Maillot, N.; Thomas, C. W.; Golden, C. T.; Gilmour, G.; Robinson, E. S.","journal":"bioRxiv","publication_date":"2026-08-12","publication_year":2026,"doi":"10.64898/2026.08.06.743309","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.06.743309","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Aging","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-08-13 01:24:42","last_checked":"2026-08-13 01:24:42","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.06.743309","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.06.743309","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.08.06.743309","source_url":"https://doi.org/10.64898/2026.08.06.743309","doi":"10.64898/2026.08.06.743309","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5859,"title":"Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and Colorado","authors":"Thompson, S.; Effinger, D.; Novick, A.; Bates, S.; Conley, A.; Tobin-Cambell, C.; Epperson, N.; Skievaski, N.","journal":"medRxiv","publication_date":"2026-08-12","publication_year":2026,"doi":"10.64898/2026.08.11.26360133","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.11.26360133","substance_tags":"psilocybin","topic_tags":"Anxiety,Wellbeing,Mystical Experience,Observational Study,Safety,Adverse Events","study_type":"Observational Study","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-08-13 01:20:49","last_checked":"2026-08-13 01:20:49","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.11.26360133","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.11.26360133","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.08.11.26360133","source_url":"https://doi.org/10.64898/2026.08.11.26360133","doi":"10.64898/2026.08.11.26360133","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5857,"title":"Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety","authors":"Salgaço Mateus Kawata, Farias David de Paulo, Souza Mariela Zucolo de, Sartoratto Adilson, Bottino Flavia, Barud Hernane da Silva, Oliveira Fellipe Lopes de, Medeiros Alexandra Ivo de, Raimundo Breno Vilas Boas, Nascimento Victor Hugo, Galdino Taynah P., Silva Suédina M. L., Fook Marcus V. L., Sivieri Katia","journal":"Drugs and Drug Candidates","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/ddc5030046","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3390/ddc5030046","substance_tags":"psilocybin,psilocin","topic_tags":"Anxiety,Pharmacology,Mechanism of Action,Animal Study,In Vitro Study,Microbiome,Inflammation,Immune Function","study_type":"In Vitro Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-13 01:20:21","bibtex":null,"source_record_id":"DOI:10.3390/ddc5030046","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/ddc5030046","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/ddc5030046","source_url":"https://doi.org/10.3390/ddc5030046","doi":"10.3390/ddc5030046","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5856,"title":"Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)","authors":"Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria","journal":"Journal of Clinical Medicine","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/jcm15166228","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3390/jcm15166228","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-13 01:20:21","bibtex":null,"source_record_id":"DOI:10.3390/jcm15166228","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jcm15166228","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jcm15166228","source_url":"https://doi.org/10.3390/jcm15166228","doi":"10.3390/jcm15166228","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3684,"title":"TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06200155","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-13 01:25:57","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06200155","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06200155","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06200155","source_url":"https://clinicaltrials.gov/study/NCT06200155","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3674,"title":"TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06801041","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-13 01:25:57","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06801041","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06801041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06801041","source_url":"https://clinicaltrials.gov/study/NCT06801041","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}}],"total":4955,"page":1,"per_page":20,"pages":248,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}